SMS Pharmaceuticals Ltd (BOM:532815)
₹ 237.1 -3.05 (-1.27%) Market Cap: 20.07 Bil Enterprise Value: 22.48 Bil PE Ratio: 40.19 PB Ratio: 3.74 GF Score: 87/100

Q3 2024 SMS Pharmaceuticals Ltd Earnings Call Transcript

Feb 12, 2024 / 10:30AM GMT
Release Date Price: ₹146.5 (+0.14%)
Operator

Ladies and gentlemen, good day, and welcome to the SMS Pharmaceuticals Limited Q3 FY24 earnings conference call. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict.

(Operator Instructions) Please note that this conference is being recorded. Today on the call we have Mr. Vamsi Krishna Potluri, Executive Director; Mr. Lakshmi Narayana Tammineedi, Chief Financial Officer; and Mr. Thirumalesh Tumma, Company Secretary and Compliance Officer. I now hand the conference over to Mr. Vamsi Krishna Potluri, Executive Director, thank you, and over to you sir.

Vamsi Potluri
SMS Pharmaceuticals Ltd - Executive Director

Thank you. Good afternoon, everyone. Thank you for joining the earnings conference call to discuss the financial performance for the quarter and nine months ended December 31, 2023. I hope everyone must

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot